×
About 4,447 results

ALLMedicine™ Primary Biliary Cirrhosis Center

Research & Reviews  2,113 results

Transcriptional regulator BOB.1: Molecular mechanisms and emerging role in chronic infl...
https://doi.org/10.1016/j.autrev.2021.102833
Autoimmunity Reviews; Yeremenko N, Danger R et. al.

Apr 17th, 2021 - Lymphocytes constitute an essential and potent effector compartment of the immune system. Therefore, their development and functions must be strictly regulated to avoid inappropriate immune responses, such as autoimmune reactions. Several lines of...

Naltrexone for cholestatic itch: a systematic review.
https://doi.org/10.1136/bmjspcare-2020-002801
BMJ Supportive & Palliative Care; Murray-Brown FL

Mar 11th, 2021 - Cholestatic itch is caused by intrahepatic liver diseases, such as primary biliary cirrhosis and extrahepatic obstruction of the biliary tree, often caused by tumours. The pathophysiology of cholestatic itch is complex and no single treatment has ...

Disease-specific waitlist outcomes in liver transplantation - a retrospective study.
https://doi.org/10.1111/tri.13814
Transplant International : Official Journal of the Europe... Nagai S, Safwan M et. al.

Jan 10th, 2021 - This study aimed to evaluate possible discrepancies in waitlist outcomes between liver diseases, including alcohol-related liver disease (ALD), nonalcoholic steatohepatitis (NASH), hepatitis C virus infection (HCV), primary biliary cirrhosis (PBC)...

Primary Biliary Cirrhosis and Granulomatous Hepatitis After Immune Checkpoint Blockade ...
https://doi.org/10.1097/CJI.0000000000000354
Journal of Immunotherapy (Hagerstown, Md. : 1997); Ruini C, Haas C et. al.

Dec 16th, 2020 - Immune-related adverse events (irAEs) of immune checkpoint inhibitors can potentially affect every organ system, are sometimes challenging, and require a multidisciplinary approach. Most common irAEs are very well characterized, but some other suc...

Autoantibody profile in eosinophilic granulomatosis and polyangiitis: predominance of a...
https://www.ncbi.nlm.nih.gov/pubmed/33200729
Clinical and Experimental Rheumatology; Laskari K, Hellmich B et. al.

Nov 17th, 2020 - To evaluate the autoantibody profile in eosinophilic granulomatosis and polyangiitis (EGPA) patients. 33 EGPA patients were tested for anti-neutrophil cytoplasmic antibodies (ANCA), antinuclear antibodies (ANA), rheumatoid factor (RF), anti-alpha-...

see more →

Guidelines  4 results

Guidelines Insights: Hepatobiliary Cancers, Version 2.2019
https://jnccn.org/view/journals/jnccn/17/4/article-p302.xml
Benson,A.,et al

Mar 31st, 2019 - Incidence and mortality rates for cancer overall are declining, but both incidence and mortality rates for hepatocellular carcinoma (HCC) are increasing.1,2 Risk factors for development of HCC include infection with hepatitis B virus (HBV) and/or ...

The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment an...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109281
Gut Hirschfield GM, Dyson JK et. al.

Mar 29th, 2018 - Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury, cholestasis and progressive fibrosis can culminate over time in an en...

The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and man...
https://gut.bmj.com/content/67/9/1568
Gideon M. Hirschfield

Mar 27th, 2018 - Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury, cholestasis and progressive fibrosis can culminate over time in an en.

Primary biliary cirrhosis.
https://doi.org/10.1002/hep.22906
Hepatology (Baltimore, Md.); Lindor KD, Gershwin ME et. al.

Jun 25th, 2009 - Primary biliary cirrhosis.|2009|Lindor KD,Gershwin ME,Poupon R,Kaplan M,Bergasa NV,|complications,diagnosis,etiology,therapy,

see more →

Drugs  31 results see all →

Clinicaltrials.gov  2,209 results

Transcriptional regulator BOB.1: Molecular mechanisms and emerging role in chronic infl...
https://doi.org/10.1016/j.autrev.2021.102833
Autoimmunity Reviews; Yeremenko N, Danger R et. al.

Apr 17th, 2021 - Lymphocytes constitute an essential and potent effector compartment of the immune system. Therefore, their development and functions must be strictly regulated to avoid inappropriate immune responses, such as autoimmune reactions. Several lines of...

Ursodiol - ursodiol tablet, film coated-Bryant Ranch Prepack
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e6ced5f-b8ef-4e6b-a7c1-730bac650c5b

Mar 28th, 2021 - Ursodiol Tablets, USP are indicated for the treatment of patients with primary biliary cirrhosis (PBC). Ursodiol tablets, USP are bile acids indicated for the treatment of patients with primary biliary cirrhosis (1)

Naltrexone for cholestatic itch: a systematic review.
https://doi.org/10.1136/bmjspcare-2020-002801
BMJ Supportive & Palliative Care; Murray-Brown FL

Mar 11th, 2021 - Cholestatic itch is caused by intrahepatic liver diseases, such as primary biliary cirrhosis and extrahepatic obstruction of the biliary tree, often caused by tumours. The pathophysiology of cholestatic itch is complex and no single treatment has ...

Ursodiol - ursodiol tablet-Strides Pharma Science Limited
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9d666bbc-98c4-445f-a5a2-cad1bcccde4e

Jan 31st, 2021 - Ursodiol tablets, USP 250 mg and 500 mg are indicated for the treatment of patients with primary biliary cirrhosis (PBC). Ursodiol tablets, USP 250 mg and 500 mg are bile acids indicated for the treatment of patients with primary biliary cirrhosis...

Disease-specific waitlist outcomes in liver transplantation - a retrospective study.
https://doi.org/10.1111/tri.13814
Transplant International : Official Journal of the Europe... Nagai S, Safwan M et. al.

Jan 10th, 2021 - This study aimed to evaluate possible discrepancies in waitlist outcomes between liver diseases, including alcohol-related liver disease (ALD), nonalcoholic steatohepatitis (NASH), hepatitis C virus infection (HCV), primary biliary cirrhosis (PBC)...

see more →

News  87 results

Scleromyxedema in a Patient With Thyroid Disease: An Atypical Case or a Case for Revised Criteria?
https://www.mdedge.com/dermatology/article/215717/mixed-topics/scleromyxedema-patient-thyroid-disease-atypical-case-or-case/page/0/1?channel=27442

Jan 17th, 2020 - Comment Classification Lichen myxedematosus is differentiated into localized and generalized forms. The former is limited to the skin and lacks monoclonal gammopathy.

Guidelines Insights: Hepatobiliary Cancers, Version 2.2019
https://jnccn.org/view/journals/jnccn/17/4/article-p302.xml
Benson,A.,et al

Mar 31st, 2019 - Incidence and mortality rates for cancer overall are declining, but both incidence and mortality rates for hepatocellular carcinoma (HCC) are increasing.1,2 Risk factors for development of HCC include infection with hepatitis B virus (HBV) and/or ...

Primary Biliary Cholangitis: The Latest Data on an Evolving Disorder
https://www.medscape.com/viewarticle/907043

Jan 3rd, 2019 - What we once called "primary biliary cirrhosis" is now termed "primary biliary cholangitis" (PBC).[1] The original name never quite fit, given that patients with PBC usually do not have cirrhosis at the time of clinical presentation.[2] "Chronic n...

Women, older patients at greater risk of more aggressive PBC
https://www.mdedge.com/gihepnews/article/174769/hepatology/women-older-patients-greater-risk-more-aggressive-pbc
Bianca Nogrady, MDedge News

Sep 13th, 2018 - A large, real-world study of primary biliary cholangitis has revealed that patients who are female, older, or have other autoimmune diseases are likely to have a more progressed and aggressive disease profile. In the Journal of Clinical Gastroente.

Antidepressant May Help in PBC
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/72292

Apr 12th, 2018 - Action Points Note that this retrospective analysis of patients with primary biliary cirrhosis found that mirtazapine use was associated with significantly improved outcomes. Be aware that mirtazapine use overall was relatively uncommon in this co...

see more →

Patient Education  3 results see all →